Utah Medical Products Stock Pattern Recognition Long Line Candle
| UTMD Stock | USD 62.64 -1.11 -1.74% |
| Symbol |
Recognition |
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of seven valid pattern recognition events for the selected time horizon. The Long Line Candle pattern shows indecision reversal trend for Utah Medical Products.
Utah Medical Technical Analysis Modules
Most technical analysis of Utah Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Utah from various momentum indicators to cycle indicators. When you analyze Utah charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. Market structure and macro sensitivity help explain how Utah Medical behaves across regimes. Price movements may be comparatively less responsive to macroeconomic volatility. Utah Medical has a market cap of 200.68 M, P/E of 31.38, ROE of 9.54%.
Methodology
Unless otherwise specified, financial data for Utah Medical Products is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Utah (USA Stocks:UTMD) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We reference public filings and market reference sources and regulatory disclosures, including those published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data may be normalized and delayed in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Utah Medical Products may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardAlign your values with your investing style
Using Utah Medical Products inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Video Games Invested few shares | |
 | Investor Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Corona Opportunity Invested few shares |
More Resources for Utah Stock Analysis
A comprehensive view of Utah Medical Products starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for Utah Medical Products Stock. Selected reports below provide context for Utah Stock:Utah Medical has a market cap of 200.68 M, operating margin of 31.11%, ROE of 9.54%. Review World Market Map for broader portfolio context. This reflects a position in Utah Medical Products within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Analysis related to Utah Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Quarterly Earnings Growth -0.06 | Dividend Share 1.225 | Earnings Share 3.48 | Revenue Per Share | Quarterly Revenue Growth -0.01 |
Understanding Utah Medical Products includes distinguishing between market value and book value, where book value reflects Utah's accounting equity. Utah Medical's market capitalization is 200.68 M. A P/B ratio of 1.7 indicates the market values Utah Medical above its accounting book value. Enterprise value stands at 117.59 M. Intrinsic value reflects what Utah Medical's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Utah Medical's value from its trading price, which are computed with different methods. For Utah Medical, key inputs include a P/E ratio of 31.38, a P/B ratio of 1.7, a profit margin of 29.3%, and ROE of 9.54%. The quoted price is simply the exchange level where supply meets demand.